Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2663-2673
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2663
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2663
Figure 2 Contrast-enhanced magnetic resonance images of the irregular tumor or enlarged hilar lymph node before and after systematic sequential therapy.
The white arrow indicates the tumor, and the white circle contains an enlarged lymph node. A: T2 phase image before therapy showing a hilar mass with a maximum diameter of 41 mm; B-D: Portal venous phase image before therapy showing that the tumor invaded the main portal vein with left and right branches, as well as the middle, left and right hepatic veins; E: Portal venous phase image before therapy showing the enlarged hilar lymph node; F: T2 phase image after therapy showing that a hilar mass shrunk to a maximum diameter of 21 mm; G-I: Portal venous phase image after therapy; J: Portal venous phase image after therapy showing that the enlarged hilar lymph nodes were smaller. RPV: Right portal vein; LPV: Left portal vein; MHV: Middle hepatic vein; RHV: Right hepatic vein; LHV: Left hepatic vein.
- Citation: Hu CL, Han X, Gao ZZ, Zhou B, Tang JL, Pei XR, Lu JN, Xu Q, Shen XP, Yan S, Ding Y. Systematic sequential therapy for ex vivo liver resection and autotransplantation: A case report and review of literature. World J Gastrointest Surg 2023; 15(11): 2663-2673
- URL: https://www.wjgnet.com/1948-9366/full/v15/i11/2663.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i11.2663